![Serge Langford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Serge Langford
Directeur/Membre du Conseil chez
Aegera Therapeutics, Inc.
Profil
Serge Langford is currently a Director at PainCeptor Pharma Corp., Aegera Therapeutics, Inc., and DalCor Pharmaceuticals Canada, Inc. He was formerly a Director at Aurelium BioPharma, Inc., Topigen Pharmaceuticals, Inc., and Thryv Therapeutics, Inc. He was also a Managing Partner at Multiple Capital, Inc. Langford received his undergraduate and graduate degrees from Hautes Etudes Commerciales.
Postes actifs de Serge Langford
| Sociétés | Poste | Début |
|---|---|---|
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Directeur/Membre du Conseil | - |
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain | Directeur/Membre du Conseil | - |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Directeur/Membre du Conseil | - |
Anciens postes connus de Serge Langford
| Sociétés | Poste | Fin |
|---|---|---|
Thryv Therapeutics, Inc.
 Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for the treatment of long qt Syndrome | Directeur/Membre du Conseil | - |
Multiple Capital, Inc.
 Multiple Capital, Inc. Investment ManagersFinance Multiple Capital focus on companies in Canada. They work closely with management team and partners to ensure their growth and to maximize return on investment. They provide early and expansion capital for companies in the high technology and life sciences sectors. | Private Equity Investor | - |
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Directeur/Membre du Conseil | - |
Aurelium BioPharma, Inc.
 Aurelium BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and diagnostics for the treatment of drug-resistant cancers | Directeur/Membre du Conseil | - |
Formation de Serge Langford
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Hautes Etudes Commerciales
 Hautes Etudes Commerciales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain | Health Technology |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Aurelium BioPharma, Inc.
Aurelium BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and diagnostics for the treatment of drug-resistant cancers | Health Technology |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
Multiple Capital, Inc.
Multiple Capital, Inc. Investment ManagersFinance Multiple Capital focus on companies in Canada. They work closely with management team and partners to ensure their growth and to maximize return on investment. They provide early and expansion capital for companies in the high technology and life sciences sectors. | Finance |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Health Technology |
Thryv Therapeutics, Inc.
Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for the treatment of long qt Syndrome | Health Services |
